ConductScience.org, home

Paper216819

Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy.

Hochberg FH and 4 others. JAMA, 1979. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy. Papers, record 216819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/216819

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy.
PubMed
Journal
JAMA
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2022-03-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hochberg FHF H
2Linggood RR
3Wolfson LL
4Baker WHW H
5Kornblith PP

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
LomustineMajor topic
Nitrosourea CompoundsMajor topic
Activities of Daily Living
Adult
Aged
Drug Tolerance
Humans
Middle Aged
Postoperative Care
Prognosis
Quality of Life
Time Factors

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42639298Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.Neurooncol Adv2026https://conductscience.org/library/papers/42639298PubMed
41501375The functional imperative in high-grade glioma.Exp Mol Med2026https://conductscience.org/library/papers/41501375PubMed
41208963Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy.Front Immunol2025https://conductscience.org/library/papers/41208963PubMed
39445563Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies.Ther Deliv2025https://conductscience.org/library/papers/39445563PubMed
38578405Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.Curr Neurol Neurosci Rep2024https://conductscience.org/library/papers/38578405PubMed
38258110Targeted Glioma Therapy-Clinical Trials and Future Directions.Pharmaceutics2024https://conductscience.org/library/papers/38258110PubMed
37894287Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/37894287PubMed
37686584The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma.Cancers (Basel)2023https://conductscience.org/library/papers/37686584PubMed
37686553Recurrent Glioblastoma: A Review of the Treatment Options.Cancers (Basel)2023https://conductscience.org/library/papers/37686553PubMed
37371674Personalized Treatment of Glioblastoma: Current State and Future Perspective.Biomedicines2023https://conductscience.org/library/papers/37371674PubMed
36673007Upstaging and Downstaging in Gliomas-Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System.Diagnostics (Basel)2023https://conductscience.org/library/papers/36673007PubMed
35849181Effectiveness of mindfulness-based supportive psychotherapy on posttraumatic growth, resilience, and self-compassion in cancer patients : A pilot study.Wien Klin Wochenschr2022https://conductscience.org/library/papers/35849181PubMed
35047971Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?Front Med Technol2021https://conductscience.org/library/papers/35047971PubMed
33810154Current FDA-Approved Therapies for High-Grade Malignant Gliomas.Biomedicines2021https://conductscience.org/library/papers/33810154PubMed
29123345Effect of Supportive Psychotherapy on Mental Health Status and Quality of Life of Female Cancer Patients Receiving Chemotherapy for Recurrent Disease.Indian J Palliat Care2017https://conductscience.org/library/papers/29123345PubMed
25821160Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.Oncotarget2015https://conductscience.org/library/papers/25821160PubMed
24590402Quality of life and brain tumors: what beyond the clinical burden?J Neurol2014https://conductscience.org/library/papers/24590402PubMed
17164049Net clinical benefit: functional endpoints in brain tumor clinical trials.Curr Oncol Rep2007https://conductscience.org/library/papers/17164049PubMed
12622451Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort.J Neurooncol2003https://conductscience.org/library/papers/12622451PubMed
8865005Quality of life in brain tumor patients.J Neurooncol1996https://conductscience.org/library/papers/8865005PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/216819

GET https://conductscience.org/api/papers/v1/216819/cited_by?page=2